Literature DB >> 14507817

Galactose toxicity in the rat as a model for premature ovarian failure: an experimental approach readdressed.

S Bandyopadhyay1, J Chakrabarti, S Banerjee, A K Pal, S K Goswami, B N Chakravarty, S N Kabir.   

Abstract

BACKGROUND: The pathophysiological mechanisms underlying premature ovarian failure (POF) are largely unknown. Our objective was to develop a working animal model to explore the pathogenesis of POF. Since galactosaemic women eventually develop POF, we evaluated the potential of experimental galactose toxicity as the proposed model.
METHODS: Pregnant rats were fed pellets supplemented with or without 35% galactose from day 3 of conception continuing through weaning of the litters. Female offspring were evaluated for serum levels of galactose and galactose-1-phosphate, growth rate, onset of puberty, reproductive cyclicity, ovarian complement of follicles, hypothalamo-pituitary-ovarian function and follicular response to gonadotrophins.
RESULTS: Galactose toxicity delayed the onset of puberty and developed a state of hypergonadotrophic hypoestrogenism. The characteristic low FSH levels at weaning followed by pubertal spurts of gonadotrophins and estradiol (E(2)) secretion of the controls was replaced by a sustained high level of FSH and a low level of E(2) under galactose toxicity. The ovary developed with apparently normal or deficient complement of follicles. Ovarian response to exogenous gonadotrophin stimulation was blunted, but the response improved significantly when the stimulation was preceded by pituitary desensitization.
CONCLUSION: Experimental galactose toxicity may serve as a model for exploring some of the basic tenets of POF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507817     DOI: 10.1093/humrep/deg414

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  32 in total

Review 1.  Diet and fertility: a review.

Authors:  Audrey J Gaskins; Jorge E Chavarro
Journal:  Am J Obstet Gynecol       Date:  2017-08-24       Impact factor: 8.661

2.  Dairy Food Intake Is Associated with Reproductive Hormones and Sporadic Anovulation among Healthy Premenopausal Women.

Authors:  Keewan Kim; Jean Wactawski-Wende; Kara A Michels; Torie C Plowden; Ellen N Chaljub; Lindsey A Sjaarda; Sunni L Mumford
Journal:  J Nutr       Date:  2016-11-23       Impact factor: 4.798

3.  Dairy intake in relation to in vitro fertilization outcomes among women from a fertility clinic.

Authors:  M C Afeiche; Y-H Chiu; A J Gaskins; P L Williams; I Souter; D L Wright; R Hauser; J E Chavarro
Journal:  Hum Reprod       Date:  2016-01-18       Impact factor: 6.918

4.  Dairy intake and fecundability in 2 preconception cohort studies.

Authors:  Lauren A Wise; Amelia K Wesselink; Ellen M Mikkelsen; Heidi Cueto; Kristen A Hahn; Kenneth J Rothman; Katherine L Tucker; Henrik Toft Sørensen; Elizabeth E Hatch
Journal:  Am J Clin Nutr       Date:  2016-11-30       Impact factor: 7.045

5.  Ginsenoside Rg1 improves fertility and reduces ovarian pathological damages in premature ovarian failure model of mice.

Authors:  Lianli He; Li Ling; Tianqin Wei; Yaping Wang; Zhengai Xiong
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

Review 6.  Galactose toxicity in animals.

Authors:  Kent Lai; Louis J Elsas; Klaas J Wierenga
Journal:  IUBMB Life       Date:  2009-11       Impact factor: 3.885

7.  Transplantation of human menstrual blood stem cells to treat premature ovarian failure in mouse model.

Authors:  Te Liu; Yongyi Huang; Jian Zhang; Wenxing Qin; Huiying Chi; Jiulin Chen; Zhihua Yu; Chuan Chen
Journal:  Stem Cells Dev       Date:  2014-04-25       Impact factor: 3.272

8.  Induction of estrogen-sensitive epithelial cells derived from human-induced pluripotent stem cells to repair ovarian function in a chemotherapy-induced mouse model of premature ovarian failure.

Authors:  Te Liu; Wenxing Qin; Yongyi Huang; Yanhui Zhao; Jiejun Wang
Journal:  DNA Cell Biol       Date:  2013-09-14       Impact factor: 3.311

Review 9.  Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell.

Authors:  Akimasa Takahashi; Abdelrahman Yousif; Linda Hong; IIana Chefetz
Journal:  J Mol Med (Berl)       Date:  2021-02-27       Impact factor: 4.599

10.  CD44+/CD105+ human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure.

Authors:  Te Liu; Yongyi Huang; Lihe Guo; Weiwei Cheng; Gang Zou
Journal:  Int J Med Sci       Date:  2012-09-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.